logo

For the Inventor, By the Inventor

Lyngby, Denmark

Anders Pedersen

This inventor holds 21 USPTO granted patents and 1 published patent application and 3 EPO patents, primarily in Pharmaceutical Innovations. Top assignees: Galecto Biotech Ab, Maxygen Holdings Ltd., Bayer Healthcare LLC. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anders Pedersen. Retrieved from https://idiyas.com/inventor/anders-pedersen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 42.9

 

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 223(Granted Patents)


Company Filing History:

goldMedal6 out of 29 
 
Galecto Biotech Ab
 patents
silverMedal6 out of 19 
 
Maxygen Holdings Ltd.
 patents
bronzeMedal5 out of 790 
 
Bayer Healthcare LLC
 patents
4. 4 out of 7 
 
Maxygen Aps
 patents
5. 1 out of 124 
 
Maxygen, Inc.
 patents
6. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Pulmonary Fibrosis
Polymorphic Forms
Galectins Inhibitors
Factor VII
Interferon Variants
Protein C
Activated Protein C
Conjugates
21 patents (USPTO):Explore Patents
1. 12774298 - Amorphous form of 5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-alpha-d-galactopyranoside (2026-10-27),
2. 11406655 - Once-daily treatment of pulmonary fibrosis (2022-08-09),
3. 10799482 - Polymorphic forms and process (2020-10-13),
4. 10730902 - 1,1 '-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins (2020-08-04),
5. 10369136 - Polymorphic forms and process (2019-08-06),
6. 10307403 - Polymorphic forms and process (2019-06-04),
7. 8084591 - Factor VII or VIIA-like molecules (2011-12-27),
8. 7754682 - Factor VII or VIIa—like molecules (2010-07-13),
9. 7598056 - Factor VII or VIIA-like molecules (2009-10-06),
10. 7517974 - Factor VII or VIIa-like molecules (2009-04-14),
11. 7511024 - Factor VII or VIIA-like molecules (2009-03-31),
12. 7442524 - Factor VII or VIIa-like molecules (2008-10-28),
13. 7427592 - Factor VII or VIIa - like molecules (2008-09-23),
14. 7414022 - Factor VII or VIIa-like molecules (2008-08-19),
15. 7371543 - Factor VII or VIIa-like molecules (2008-05-13),

Title: Innovations of Anders Pedersen in Pulmonary Treatments

Introduction

Anders Pedersen, a prolific inventor based in Lyngby, Denmark, holds an impressive portfolio of 20 patents. His work primarily focuses on innovations in the medical field, particularly in treatments for pulmonary diseases. Pedersen's contributions have significantly impacted the way pulmonary fibrosis is approached and treated.

Latest Patents

Among his latest inventions is a groundbreaking patent related to the once-daily treatment of pulmonary fibrosis. This invention involves a compound of a specific formula designed for effective administration to the human lung. The unique aspect of this treatment is its targeted delivery to the narrowest parts of lung tissue, ensuring optimal therapeutic outcomes. Additionally, he has developed a patent concerning polymorphic forms and processes for preparing an amorphous compound. This form is tailored for treating idiopathic pulmonary fibrosis (IPF) through pulmonary administration, showcasing his commitment to advancing treatment methodologies.

Career Highlights

Throughout his career, Anders Pedersen has made significant strides in pharmaceutical research and development. He has worked with renowned companies such as Maxygen Holdings Ltd. and Bayer Healthcare LLC. His experiences in these organizations have undoubtedly contributed to his innovative thinking and patent filings.

Collaborations

In addition to his work with major companies, Anders has collaborated with talented colleagues, including Kim Vilbour Andersen and Claus Bornaes. These partnerships have fostered a rich environment for creativity and the advancement of new ideas within the realm of pulmonary treatment innovations.

Conclusion

Anders Pedersen's contributions to the field of pulmonary disease treatment through his patents reflect his dedication to medical innovation. His inventive spirit and collaborations have positioned him as a notable figure in the field, and his work continues to inspire advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…